Alembic Pharmaceuticals Limited

This company manufactures and markets generic pharmaceutical products globally, with a focus on research and development.

2010 | Vadodara, Gujarat (India) | Active
Last Updated:

Alembic Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 40.50 Cr
  • Paid Up Capital ₹ 39.31 Cr
  • Company Age 14 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 600.00 Cr
  • Satisfied Charges ₹ 219.36 Cr
  • Revenue Growth 1.30%
  • Profit Growth -36.21%
  • Ebitda -26.90%
  • Net Worth -16.56%
  • Total Assets -13.34%

About Alembic Pharmaceuticals

Alembic Pharmaceuticals Limited (APL) is a leading Public Limited Indian Non-Government Company incorporated in India on 16 June 2010 and has a history of 14 years and nine months. Its registered office is in Vadodara, Gujarat, India.

It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 533573 and on the National Stock Exchange(NSE) under APLLTD.

The Corporate was formerly known as Alembic Pharma Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 40.50 Cr and a paid-up capital of Rs 39.31 Cr.

The company currently has active open charges totaling ₹600.00 Cr. The company has closed loans amounting to ₹219.36 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Alembic Pharmaceuticals Limited India are Chirayu Amin as Ceo, R Baheti as Cfo, and Manisha Kathed as Company Secretary. Manish Kejriwal, Geeta Goradia, Chirayu Amin, and Five other members serve as directors at the Company.

Company Details

  • Location

    Vadodara, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    L24230GJ2010PLC061123

  • Company No.

    061123

  • Stock Symbol

    BSE : 533573 NSE : APLLTD

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    16 Jun 2010

  • Date of AGM

    22 Jul 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Listed

  • ROC Code

    Roc Ahmedabad

Industry

Pharma

What products or services does Alembic Pharmaceuticals Limited offer?

Alembic Pharmaceuticals Limited offers a wide range of products and services, including Women Care, Mother Care, Health Conditions, Fever, Hair Care, Hair Growth for Men, Vitamins & Supplements, Mineral Supplements, Specialty Supplements, Probiotics.

Company report

Alembic Pharmaceuticals Limited

Explore comprehensive data for Alembic Pharmaceuticals Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Alembic Pharmaceuticals?

Executive Team (5)

NameDesignationAppointment DateStatus
Pranav Amin Country flag representing In Managing Director31-Mar-2011Current
Shaunak Amin Country flag representing In Managing Director02-May-2013Current
Chirayu Amin Country flag representing In CEO27-Apr-2016Current
R Baheti Country flag representing In CFO28-Jul-2014Current
Manisha Kathed Country flag representing In Company Secretary01-Apr-2023Current

Board Members (6)

NameDesignationAppointment DateStatus
Manish Kejriwal Country flag representing In Director 31-Mar-2024Current
Geeta Goradia Country flag representing In Director 03-Feb-2025Current
Ashok Barat Country flag representing In Director 10-Feb-2022Current
Chirayu Amin Country flag representing In Whole-Time Director and Ceo 16-Jun-2010Current
Rajkumar Baheti Country flag representing In Whole-Time Director and Cfo 16-Jun-2010Current
Jai Diwanji Country flag representing In Director 05-May-2023Current

Financial Performance of Alembic Pharmaceuticals.

Alembic Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.3% increase. The company also saw a substantial fall in profitability, with a 36.21% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.56%.

Alembic Pharmaceuticals revenue growth over time
Alembic Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
1.30%
Revenue from Operations
2.26%
Total Assets
-13.34%
Profit or Loss
-36.21%
Net Worth
-16.56%
EBITDA
-26.90%

What is the Ownership and Shareholding Structure of Alembic Pharmaceuticals?

In 2023, Alembic Pharmaceuticals had a promoter holding of 69.61% and a public holding of 30.40%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹600.00 Cr

Satisfied Charges

₹219.36 Cr

Charges Breakdown by Lending Institutions

  • Others : 600.00 Cr

Latest Charge Details

DateLenderAmountStatus
30 Jun 2011Others₹600.00 CrOpen
19 Nov 2021Hdfc Bank Limited₹5.00 CrSatisfied
26 Jul 2021Yes Bank Limited₹10.00 CrSatisfied
08 May 2014Bank Of Baroda₹1.36 CrSatisfied
02 Dec 2011Dbs Bank Limited₹78.00 CrSatisfied

How Many Employees Work at Alembic Pharmaceuticals?

Alembic Pharmaceuticals has a workforce of 15822 employees as of Feb 11, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Alembic Pharmaceuticals Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Alembic Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alembic Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Alembic Pharmaceuticals

Recent activity within the organization

  • Director Appointment

    Geeta Amit Goradia was appointed as a Director was appointed as a Director on 03 Feb 2025 & has been associated with this company since 2 months 11 days .

  • Annual General Meeting

    Alembic Pharmaceuticals Limited last Annual general meeting of members was held on 22 Jul 2024 as per latest MCA records.

  • Balance Sheet

    Alembic Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.

  • Director Appointment

    Manish Santoshkumar Kejriwal was appointed as a Director was appointed as a Director on 31 Mar 2024 & has been associated with this company since 1 year 14 days .

  • Charges

    A charge registered on 26 Jul 2021 via Charge ID 100469987 with Yes Bank Limited was fully satisfied on 13 Jun 2023.

  • Director Appointment

    Jai Shishir Diwanji was appointed as a Director was appointed as a Director on 05 May 2023 & has been associated with this company since 1 year 11 months .

Recent News, Updates & Announcement

Frequently asked questions

  • What is the Incorporation or founding date of Alembic Pharmaceuticals Limited?

    Alembic Pharmaceuticals Limited was incorporated on 16 Jun 2010.

  • What is authorized share capital and paid-up capital of Alembic Pharmaceuticals Limited?

    The authorized share capital of Alembic Pharmaceuticals Limited is ₹ 40.50 Cr and paid-up capital is ₹ 39.31 Cr.

  • Who are the current board members & directors of Alembic Pharmaceuticals Limited?

    Currently 11 directors are associated with Alembic Pharmaceuticals Limited.

    • Manish Santoshkumar Kejriwal
    • Geeta Amit Goradia
    • Chirayu Ramanbhai Amin
    • Pranav Chirayu Amin
    • Shaunak Chirayu Amin
    • Rajkumar Shreeram Baheti
    • Ashok Kumar Barat
    • Jai Shishir Diwanji
    • Chirayu Ramanbhai Amin
    • R K Baheti
    • Manisha Kathed

  • What is the registered address of Alembic Pharmaceuticals Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Alembic Pharmaceuticals Limited is Alembic Road, India, Vadodara, Gujarat, 390003.

  • What is the corporate identification number (CIN) and company number of Alembic Pharmaceuticals Limited?

    The corporate identification number (CIN) of Alembic Pharmaceuticals Limited is L24230GJ2010PLC061123 and the company number is 061123 as per Ministry of Corporate Affairs (MCA).

  • Is Alembic Pharmaceuticals Limited registered with any stock exchange in India?

    Yes, Alembic Pharmaceuticals Limited is registered on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE): APLLTD.

  • What is the official website of Alembic Pharmaceuticals Limited?

    The Official website of Alembic Pharmaceuticals Limited is https://www.alembicpharmaceuticals.com

  • What has been the recent revenue trend for Alembic Pharmaceuticals Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Alembic Pharmaceuticals Limited has risen by 1.30%.

  • How many employees does Alembic Pharmaceuticals Limited currently have?

    As Per 2023 financial reports, 15822 employees are currently employed by Alembic Pharmaceuticals Limited.

  • What change has been observed in the net worth of Alembic Pharmaceuticals Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Alembic Pharmaceuticals Limited has experienced an downturn of -16.56%.

  • What are the total open charges for Alembic Pharmaceuticals Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Alembic Pharmaceuticals Limited amount to ₹ 600.00 Cr.

  • When was the last Balance Sheet of Alembic Pharmaceuticals Limited filed with the ROC?

    The most recent Balance Sheet for Alembic Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on API Manufacturers